Es gab 50 kürzliche Insider-Transaktionen für Evoke Pharma, Inc. (EVOK), darunter 42 Käufe und 2 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $1.95M und die gesamten Insider-Verkäufe auf $30.25K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Nantahala Capital Management, Llc, Garner Cam L, Widder Kenneth J. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — EVOK
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2029-02-13 |
Nantahala Capital Management, Llc |
10 Percent Owner |
Unbekannt |
117,019 |
$8.16 |
$954.88K |
- |
| 2025-05-21 |
Garner Cam L |
Director |
RSU-Zuteilung |
1,291 |
$3.45 |
$4.46K |
11,520 |
| 2025-05-21 |
Widder Kenneth J |
Director |
RSU-Zuteilung |
1,187 |
$3.45 |
$4.1K |
8,207 |
| 2025-05-21 |
Reed Vickie S |
Director |
RSU-Zuteilung |
1,250 |
$3.45 |
$4.32K |
8,333 |
| 2025-05-21 |
Hill Malcolm R |
Director |
RSU-Zuteilung |
1,218 |
$3.45 |
$4.21K |
8,269 |
| 2025-05-21 |
Brady Todd C |
Director |
RSU-Zuteilung |
1,187 |
$3.45 |
$4.1K |
8,238 |
| 2025-05-21 |
Smeal Benjamin C. |
Director |
RSU-Zuteilung |
1,125 |
$3.45 |
$3.88K |
6,958 |
| 2025-05-21 |
Pyszczymuka Greg |
Director |
RSU-Zuteilung |
1,155 |
$3.45 |
$3.99K |
6,988 |
| 2025-03-21 |
D'onofrio Matthew J |
Chief Executive Officer |
RSU-Zuteilung |
1,000 |
$2.80 |
$2.8K |
9,820 |
| 2025-03-20 |
Kowieski Mark |
Chief Financial Officer |
RSU-Zuteilung |
4,500 |
$3.21 |
$14.46K |
4,916 |
| 2025-02-28 |
D'onofrio Matthew J |
Chief Executive Officer |
RSU-Zuteilung |
6,849 |
$3.65 |
$25K |
8,820 |
| 2025-02-20 |
Pyszczymuka Greg |
Director |
Unbekannt |
- |
- |
- |
- |
| 2025-02-20 |
Pyszczymuka Greg |
Director |
RSU-Zuteilung |
5,833 |
$5.26 |
$30.68K |
5,833 |
| 2025-01-28 |
Garner Cam L |
Director |
RSU-Zuteilung |
8,750 |
$4.45 |
$38.94K |
8,750 |
| 2025-01-28 |
Widder Kenneth J |
Director |
RSU-Zuteilung |
5,833 |
$4.45 |
$25.96K |
5,833 |
| 2025-01-28 |
Reed Vickie S |
Director |
RSU-Zuteilung |
5,833 |
$4.45 |
$25.96K |
5,833 |
| 2025-01-28 |
D'onofrio Matthew J |
Chief Executive Officer |
RSU-Zuteilung |
70,000 |
$4.45 |
$311.5K |
70,000 |
| 2025-01-28 |
Hill Malcolm R |
Director |
RSU-Zuteilung |
5,833 |
$4.45 |
$25.96K |
5,833 |
| 2025-01-28 |
Brady Todd C |
Director |
RSU-Zuteilung |
5,833 |
$4.45 |
$25.96K |
5,833 |
| 2025-01-28 |
Carlson Marilyn R. |
Chief Medical Officer |
RSU-Zuteilung |
11,000 |
$4.45 |
$48.95K |
11,000 |
| 2025-01-28 |
Kowieski Mark |
Chief Financial Officer |
RSU-Zuteilung |
13,000 |
$4.45 |
$57.85K |
13,000 |
| 2025-01-28 |
Nantahala Capital Management, Llc |
10 Percent Owner |
Informierter Verkauf |
41 |
$4.39 |
$179.87 |
148,153 |
| 2024-11-06 |
Nantahala Capital Management, Llc |
10 Percent Owner |
Unbekannt |
- |
- |
- |
148,194 |
| 2024-10-18 |
Smeal Benjamin C. |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-10-18 |
Smeal Benjamin C. |
Director |
RSU-Zuteilung |
5,833 |
$5.51 |
$32.14K |
5,833 |
| 2024-09-27 |
Nantahala Capital Management, Llc |
10 Percent Owner |
Unbekannt |
250,627 |
$0.01 |
$2.51K |
- |
| 2024-08-07 |
D'onofrio Matthew J |
Chief Executive Officer |
RSU-Zuteilung |
64,840 |
$5.27 |
$341.71K |
64,840 |
| 2024-08-07 |
Carlson Marilyn R. |
Chief Medical Officer |
RSU-Zuteilung |
17,291 |
$5.27 |
$91.12K |
17,291 |
| 2024-08-07 |
Kowieski Mark |
Chief Financial Officer |
RSU-Zuteilung |
17,291 |
$5.27 |
$91.12K |
17,291 |
| 2024-05-22 |
Garner Cam L |
Director |
RSU-Zuteilung |
17,750 |
$0.45 |
$8.01K |
17,750 |
| 2024-05-22 |
Widder Kenneth J |
Director |
RSU-Zuteilung |
14,250 |
$0.45 |
$6.43K |
14,250 |
| 2024-05-22 |
Reed Vickie S |
Director |
RSU-Zuteilung |
15,000 |
$0.45 |
$6.77K |
15,000 |
| 2024-05-22 |
Hill Malcolm R |
Director |
RSU-Zuteilung |
14,625 |
$0.45 |
$6.6K |
14,625 |
| 2024-05-22 |
Brady Todd C |
Director |
RSU-Zuteilung |
14,625 |
$0.45 |
$6.6K |
14,625 |
| 2024-05-22 |
Kowieski Mark |
Chief Financial Officer |
Veräußerung |
7,500 |
$4.01 |
$30.08K |
- |
| 2024-02-13 |
Nantahala Capital Management, Llc |
10 Percent Owner |
Unbekannt |
245,080 |
$8.16 |
$2M |
- |
| 2023-05-10 |
Garner Cam L |
Director |
RSU-Zuteilung |
17,750 |
$2.12 |
$37.63K |
17,750 |
| 2023-05-10 |
Widder Kenneth J |
Director |
RSU-Zuteilung |
14,250 |
$2.12 |
$30.21K |
14,250 |
| 2023-05-10 |
Reed Vickie S |
Director |
RSU-Zuteilung |
15,000 |
$2.12 |
$31.8K |
15,000 |
| 2023-05-10 |
Hill Malcolm R |
Director |
RSU-Zuteilung |
14,625 |
$2.12 |
$31.01K |
14,625 |
| 2023-05-10 |
Brady Todd C |
Director |
RSU-Zuteilung |
14,625 |
$2.12 |
$31.01K |
14,625 |
| 2023-02-08 |
Gonyer David A |
CEO |
RSU-Zuteilung |
30,000 |
$4.01 |
$120.3K |
30,000 |
| 2023-02-08 |
D'onofrio Matthew J |
President & Chief Op. Officer |
RSU-Zuteilung |
25,000 |
$4.01 |
$100.25K |
25,000 |
| 2023-02-08 |
Carlson Marilyn R. |
Chief Medical Officer |
RSU-Zuteilung |
15,000 |
$4.01 |
$60.15K |
15,000 |
| 2022-04-27 |
Garner Cam L |
Director |
RSU-Zuteilung |
67,500 |
$0.66 |
$44.55K |
67,500 |
| 2022-04-27 |
Widder Kenneth J |
Director |
RSU-Zuteilung |
56,000 |
$0.66 |
$36.96K |
56,000 |
| 2022-04-27 |
Reed Vickie S |
Director |
RSU-Zuteilung |
58,000 |
- |
- |
58,000 |
| 2022-04-27 |
Hill Malcolm R |
Director |
RSU-Zuteilung |
57,750 |
$0.66 |
$38.12K |
57,750 |
| 2022-04-27 |
Brady Todd C |
Director |
RSU-Zuteilung |
57,750 |
$0.66 |
$38.12K |
57,750 |
| 2022-02-02 |
Gonyer David A |
President and CEO |
RSU-Zuteilung |
175,000 |
$0.55 |
$96.25K |
175,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
